Brief

On February 14, 2025, the Italian Medicines Agency (AIFA) issued an update regarding AIFA President Robert Nisticò. The update emphasized the significance of the Interceptor project in identifying biomarkers that can predict individuals with mild cognitive disorders who are more likely to develop Alzheimer's disease.

This content is restricted.

Highlights content goes here...

This content is restricted.

Italian Medicines Agency (AIFA)

Quick Insight
RADA.AI
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Enter your registered username/email id.

Enter your Email

Enter your email id below to signup.
Individual Plan
$125 / month OR $1250 / year
Features
Best for: Researchers, Legal professionals, Academics
Enterprise Plan
Contact for Pricing
Features
Best for: Law Firms, Corporations, Government Bodies